Target intelligence / Profile preview

RNA, U6 small nuclear 311, pseudogene (RNU6-311P)

Target
RNU6-311P
Molecular classification
Other (Pseudogene; small nuclear RNA-related sequence)
01

Overview

RNA, U6 small nuclear 311, pseudogene (RNU6-311P) is a human pseudogene that shares sequence similarity with the U6 small nuclear RNA (snRNA), an essential RNA of the spliceosome complex required for pre-mRNA splicing. Unlike the functional U6 snRNA, RNU6-311P is classified as a pseudogene, meaning it is generally not transcribed or functional as a mature RNA molecule, nor is it involved in canonical splicing activity[4][5]. Pseudogenes like RNU6-311P do not encode proteins or functional RNAs and are not considered therapeutic targets. They are typically the result of gene duplication or retrotransposition events and may be used as genomic markers or in evolutionary studies, but they are not known to play a direct role in disease mechanisms or as drug targets[2][4][5]. Key notes: - RNU6-311P is catalogued in human gene databases and identified as a pseudogene without known functional RNA expression or direct biological activity[4][5]. - Functional U6 snRNA genes are highly conserved and essential for spliceosome assembly and RNA splicing, but pseudogenes like RNU6-311P represent inactive genomic copies without such roles[3][5]. - No evidence exists for direct disease association, biomarker use, or drug targeting for this specific pseudogene[4][5]. - Many U6-derived pseudogenes exist in the vertebrate genome, reflecting the evolutionary importance of the original U6 gene, but these pseudogenes generally lack functional significance[5].

Other names
RNU6-311PRNA, U6 small nuclear 311, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 311, pseudogene (RNU6-311P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 311, pseudogene (RNU6-311P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call